The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Purpose. The goal of these studies was to provide proof of concept for a novel targeted therapy for Glioblastoma Multiforme (GBM). Methods. These studies involve the evaluation of reconstituted high density lipoprotein (rHDL) nanoparticles (NPs) as delivery agents for the drug, mammalian Target of R...

Full description

Bibliographic Details
Main Authors:	Ethan Berney, Nirupama Sabnis, Marlyn Panchoo, Sangram Raut, Rob Dickerman, Andras G. Lacko
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2019/1805841

Similar Items

Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
by: Linda K Mooberry, et al.
Published: (2016-12-01)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
by: Sangram Raut, et al.
Published: (2018-10-01)

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
by: Johnson R, et al.
Published: (2017-06-01)

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013-06-01)

Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
by: Sabnis S, et al.
Published: (2017-02-01)

TARGETED NANOPARTICLES FOR PEDIATRIC LEUKEMIA THERAPY
by: Riyaz eBasha, et al.
Published: (2014-05-01)

HDL as a drug and nucleic acid delivery vehicle
by: Andras G Lacko, et al.
Published: (2015-10-01)

Vyjadrenie závislej práce v poisťovacom systéme SR
by: Miloš Lacko
Published: (2019-03-01)

Drug Conjugates for Targeting Eph Receptors in Glioblastoma
by: Puja Sharma, et al.
Published: (2020-04-01)

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
by: Manali Tilak, et al.
Published: (2021-02-01)

Pre-clinical evaluation of rHDL encapsulated retinoids for the treatment of Neuroblastoma
by: Nirupama eSabnis, et al.
Published: (2013-03-01)

Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
by: Suhas Vasaikar, et al.
Published: (2018-02-01)

The role of cholesterol metabolism and cholesterol transport in carcinogenesis; A review of scientific findings, relevant to future cancer therapeutics.
by: Pedro Miguel Cruz, et al.
Published: (2013-09-01)

Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
by: Sadhak Sengupta, et al.
Published: (2014-01-01)

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
by: Ali S. Arbab, et al.
Published: (2017-12-01)

Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
by: Fahim Ahmad, et al.
Published: (2019-01-01)

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
by: Mélanie Rose, et al.
Published: (2021-09-01)

Cathepsin S as a potential therapeutic target in radioresistant glioblastoma
by: Foster, Robyn
Published: (2017)

CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction
by: Jan F.C. Glatz, et al.
Published: (2020-01-01)

Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma
by: Pragya Gupta, et al.
Published: (2020-12-01)

Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches
by: Oana Alexandru, et al.
Published: (2020-03-01)

How we treat glioblastoma
by: Jörg-Christian Tonn, et al.
Published: (2019-05-01)

Potential targets of TMEM176A in the growth of glioblastoma cells
by: Liu Z, et al.
Published: (2018-11-01)

Epigenetic Targeting of Glioblastoma
by: Massimo Romani, et al.
Published: (2018-10-01)

Targeting Immunometabolism in Glioblastoma
by: Aditya A. Mohan, et al.
Published: (2021-06-01)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
by: Aisling M. Glynn, et al.
Published: (2019-08-01)

Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma
by: Xin Tang, et al.
Published: (2021-03-01)

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
by: Julie Bolcaen, et al.
Published: (2021-06-01)

Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK
by: Marius Grzelinski, et al.
Published: (2009-02-01)

A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma
by: Efrat Shavit-Stein, et al.
Published: (2018-12-01)

Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
by: Yuekun Wang, et al.
Published: (2020-11-01)

Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas
by: Yang Xu, et al.
Published: (2018-01-01)

Glioblastoma: approach to treat elderly patients
by: Luciola de Barros Pontes, et al.

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
by: Rasime Kalkan
Published: (2015-11-01)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
by: Rasime Kalkan
Published: (2015-01-01)

The 5-HT-7 receptor as a potential target for treating drug and alcohol abuse
by: Sheketha R. Hauser, et al.
Published: (2015-01-01)

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
by: Gregory C. Stachelek, MD, PhD, et al.
Published: (2020-01-01)

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresResearch in context
by: Dean Nehama, et al.
Published: (2019-09-01)

Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient’s Survival
by: Maria Beatrice Morelli, et al.
Published: (2019-04-01)